SW
WHWK

SVB Wealth’s Whitehawk Therapeutics WHWK Stock Holding History

SVB Wealth’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16
Closed -$28 – 1710
2025
Q1 		$28 Buy
+16
New +$42 ﹤0.01% 1512

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SVB Wealth's WHWK Position: Q2 2025 in Review

SVB Wealth sold out of Whitehawk Therapeutics (WHWK) in Q2 2025, closing a stake of 16 shares — an estimated $28 sold.

SVB Wealth first reported a position in WHWK in Q1 2025 and held it in 1 quarter. The position peaked at $28 in Q1 2025. 39 funds tracked by Wall St. Rank hold WHWK as of Q2 2025.

  • SVB Wealth reported no remaining Whitehawk Therapeutics position as of Q2 2025 after selling out during the quarter.
  • SVB Wealth sold 16 Whitehawk Therapeutics shares in Q2 2025, an estimated $28.
  • SVB Wealth first reported a position in Whitehawk Therapeutics in Q1 2025 and held it in 1 quarter.
  • SVB Wealth's Whitehawk Therapeutics position peaked at $28 in Q1 2025.
  • 39 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.